San Diego,April 20, 2015Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim and t:flex Insulin Pumps, today commenced shipments of t:slim Pumps featuring enhanced software.The updated software, based oncustomer and healthcare provider feedback,includes an expansion of the reverse correction function, the ability to enter a manual bolus directly in the suggested bolus window, off-pump cartridge filling, and other features to enhance convenience and flexibility.
Tandem is actively working on a project to provide current t:slim Pump users the ability to update their pump software remotely, similar to other modern consumer devices. The Company plans to submit a filing for this remote update capability to the U.S. Food and Drug Administration (FDA) later this year.
Innovation is at the heart of our company, as is listening to our customers, said Kim Blickenstaff, President and CEO of Tandem Diabetes Care. As we enhance our products, we want to offer the new features to our existing customers as quickly as possible. The ability to remotely update pumps is a way to do this, and we look forward to working with the FDA to bring our customers this benefit.